ByTrending Posts
Is HEALWELL AI’s Acquisition of BioPharma Canada’s Biggest…
Key Highlights HEALWELL Targets AI-Driven Scale in CRO with $14.4M BioPharma AcquisitionHEALWELL AI Inc. (TSX: AIDX, OTCQX: HWAIF)…
How Merck’s $3B MoonLake Acquisition the AI-Powered Bet…
Key Highlights Merck Moves Decisively: A $3 Billion Signal to the Late-Stage Biotech MarketMerck has reportedly offered over…
Can HekaBio and Alfresa’s AI-Driven Alliance Redefine Japan’s…
Smart Partnerships: HekaBio Leverages Alfresa’s Scale to Localize Global InnovationJapan’s historically delayed access to global therapies may soon…
China focus: Is AstraZeneca’s $5.3B AI-Powered Alliance with…
Key Takeaways: AI as the Catalyst: CSPC’s Dual-Engine Platform Front and CenterAt the core of this partnership lies…
Can Ellipsis Health’s $45M Series A and Launch…
Key Insights: Sage Redefines AI Care Management with Empathy at the CoreEllipsis Health is introducing Sage, an emotionally…
How Tempus AI and Northwestern Use AI to…
Key Takeaways Transforming Alzheimer’s Research with AI and Precision GenomicsIn a multi-year collaboration announced today, Tempus AI (NASDAQ:…
Can Parallel Bio’s $21M Bet on Immune Organoids…
Key Highlights Organoid-AI Platform Aims to Transform Preclinical Drug DiscoveryParallel Bio’s proprietary platform replicates the human immune system…
Can BullFrog AI and Sygnature Discovery’s $30M Alliance…
Key Highlights BullFrog AI Secures Global CRO Partner to Scale AI PlatformBullFrog AI has entered a commercial collaboration…
Can Receptor.AI’s Integration of REAXENSE™ Platform Redefine Full-Stack…
Key Insights: Advanced Chemistry at ScaleReceptor.AI has incorporated the REAXENSE™ platform, developed by Canada-based Reaxense Inc., into its…
Trending Posts
Latest Stories
Can Merck’s $300 Million AI Investment in 2025 — Fueled by Strategic Partnerships — Accelerate Innovation, R&D and Commercial Success in 2026?
Global – December 31, 2025 — Merck & Co., Inc. significantly expanded its commitment to…
Can Gilead’s $260 Million AI Investment in 2025 — Backed by Strategic AI Initiatives — Accelerate Discovery, R&D, and Commercial Impact in 2026?
Global – December 31, 2025 — Gilead Sciences, Inc. expanded its commitment to artificial intelligence…
Can Sanofi’s $380 Million AI Investment in 2025 — Bolstered by Strategic Partnerships — Drive Breakthroughs in Discovery, R&D, and Commercial Success in 2026?
Global – December 31, 2025 — Sanofi S.A. made significant investments in artificial intelligence (AI)…
Can Roche’s $420 Million AI Investment in 2025 — Backed by Strategic AI Deals — Boost Discovery, R&D, and Commercial Advantage in 2026?
Global – December 31, 2025 — Roche Holding AG, a global leader in pharmaceuticals and…
Gallery
